American Federation for Aging Research Grants for Junior Faculty and Glenn Foundation for Medical Research (GFMR) Grants for Junior Faculty provide up to $160,000 for a one- to two-year award to early career faculty (MDs and PhDs) to conduct research that will serve as the basis for longer term research efforts on the biology of aging. These investigators study a broad range of biomedical and clinical topics related to aging. [The Letter of Intent deadline is December 15, 2025. The deadline for full applications is late April 2026.]
Aging-Related Funding
2025 IBSA Foundation Fellowships
IBSA Foundation for scientific research offers 6 Fellowships of €32’000 in the following research field: dermatology, endocrinology, fertility/urology, pain medicine/orthopaedics/rheumatology, and healthy aging/regenerative medicine. Two grants will be awarded to the scientific area with the highest number of projects received. Applicants of any nationality must be under 40 years old on the deadline for the submission of proposals. They must have a degree in medicine, biology, pharmacy, biotechnology or bioengineering. Open to PhD students, PhD, Post-Doc and residents. Permanent positions such as Professors cannot apply. [Application deadline: 1/31/26]
NIH Blueprint for Neuroscience: Coordination Center for Interoception Research (BPCCIR) (U24, Clinical Trial Not Allowed)
This NOFO aims to foster interactions within the broad community of interoception researchers rather than focusing on disease-specific subdisciplines. Proposed efforts should: 1) establish and maintain a multidisciplinary team of interoception researchers to oversee and guide NBCCIR activities; 2) create and support digital communication platforms to facilitate networking, collaborations, and information dissemination; 3) plan, organize, and host at least one scientific meeting per year that will include NIH-funded interoception researchers, trainees, and other stakeholders; 4) identify challenges and future technological and scientific opportunities for the field of interoception and develop common terminology, data standards, and common data elements; and 5) generate metrics of success and plans to ensure the sustainability of the interoception research community. [Posted 9/2/2025. Due 11/10/2025.]
NIH Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required)
PA-25-307: The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This Parent Notice of Funding Opportunity is for basic science experimental studies involving humans (per NOT-OD-18-212, “prospective basic science studies involving human participants”). [Posted 12/18/2024. Expires 01/08/2028.]
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
The purpose of the Stephen I. Katz Early Stage Investigator Research Project Grant is to provide a new pathway for Early Stage Investigators (ESIs) who wish to propose research projects in a new direction for which preliminary data do not exist. This notice of funding opportunity (NOFO) is open to a broad range of scientific research relevant to the mission of the participating NIH Institutes and Centers (ICs).
[Posted August 25, 2025. Expires August 26, 2028.]
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
The purpose of the Stephen I. Katz Early Stage Investigator Research Project Grant is to provide a new pathway for Early Stage Investigators (ESIs) who wish to propose research projects in a new direction for which preliminary data do not exist. This notice of funding opportunity (NOFO) is open to a broad range of scientific research relevant to the mission of the participating NIH Institutes and Centers (ICs). Proposed projects must represent a change in research direction for the ESI and should be innovative and unique. A distinct feature for this NOFO is that applications must not include preliminary data.
[Posted 8/25/2025. Expires 8/26/2028.]
NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)
NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed). The purpose of the NIA K22 Career Transition Award is to facilitate the transition of mentored, postdoctoral researchers to tenure-track or equivalent faculty positions conducting research that advances the mission of NIA. This award does not provide postdoctoral phase funding; therefore, candidates should be prepared to transition to tenure-track or equivalent faculty positions within 12 months after confirmation of a positive funding decision. After transition to an approved faculty position at an extramural institution/organization, the award will provide three years of protected research time through salary and research support. [Posted on 2/13/2024. Expires on 11/13/2025]
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed). The purpose of this notice of funding opportunity (NOFO) is to provide support for established investigators who have the expertise and leadership skills to enhance aging and/or Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) research capacity within their academic institution. [Posted on 11/6/2024. Expires on 11/13/2027]
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required). This Notice of Funding Opportunity (NOFO) invites applications for implementation of investigator-initiated multi-site interventional clinical trials (all phases). The trials should be hypothesis-driven, milestone-defined, and related to NIA’s research mission. Information about NIA’s mission can be found on the NIA website. [Posted on 11/6/2024. Expires on 1/8/2026]
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed). This Notice of Funding Opportunity (NOFO) encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems (MPS) and related assays that replicate complex nervous system architectures and physiology with improved fidelity over current capabilities. Supported projects will be expected to enable future studies of complex nervous system development, function and aging in healthy and disease states. [Posted on 11/6/2024. Expires on 1/8/2026]